Year-End Report — CEPHALON, INC. for CEPHALON INC (2007)

Firm

CEPHALON, INC.

Client

CEPHALON INC

Income

—

Expenses

$531,219

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Brazilian intellectual property issues

Lobbyist	Covered position, as disclosed
JENNIFER MICHELE CONNELLY	N/A
JEFF M MYERS	N/A
KIM ZIMMERMAN	N/A

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA)

Copyright/Patent/Trademark CPT

H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.

Lobbyist	Covered position, as disclosed
JENNIFER MICHELE CONNELLY	N/A
JEFF M MYERS	N/A
KIM ZIMMERMAN	N/A

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; State, Dept of (DOS)

Bills named: H.R. 2642 (110th), H.R. 5418 (110th), H.R. 1432 (110th), H.R. 2795 (110th), S. 3582 (110th)

Alcohol and Drug Abuse ALC

Support for standards for new pharmaceuticals therapies for the treatment of alcoholism. Mental Health Parity

Lobbyist	Covered position, as disclosed
JENNIFER MICHELE CONNELLY	N/A
JEFF M MYERS	N/A
KIM ZIMMERMAN	N/A

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); State, Dept of (DOS); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Health Issues HCR

P.L. 109-57, implementation of export regulations for controlled substances S.3807, Senators Enzy, Kennedy, Drug Safety legislation, "Enhancing Drug Safety & Innovation Act of 2006." Section 1. riskmaps; section 4. Advisory committees; approval standards for pharmaceuticals. H.R. 3162 SCIP; H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007.

Lobbyist	Covered position, as disclosed
JENNIFER MICHELE CONNELLY	N/A
JEFF M MYERS	N/A
KIM ZIMMERMAN	N/A

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); SENATE; State, Dept of (DOS); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 3807 (110th), H.R. 3162 (110th), H.R. 4 (110th)

Budget/Appropriations BUD

H.Con.Res 95. Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043, Labor-HHS Education Appropriations

Lobbyist	Covered position, as disclosed
JENNIFER MICHELE CONNELLY	N/A
JEFF M MYERS	N/A
KIM ZIMMERMAN	N/A

Contacted: Drug Enforcement Administration (DEA); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Bills named: H.R. 3043 (110th), H.Con.Res. 95 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.